Skip to content

Disc Medicine IRON Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$635M-220%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$417.1M+268%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$65.32M+54.0%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$24.47M+801%
Beam Therapeutics logo
Beam TherapeuticsBEAM
-$6.64M-103%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-$14.67M-536%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's net change in cash?
Disc Medicine (IRON) reported net change in cash of -$2.23M in Q1 2026.
How has Disc Medicine's net change in cash changed year-over-year?
Disc Medicine's net change in cash increased by 96.8% year-over-year, from -$69.76M to -$2.23M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.